Junshi Biosciences Announces Acceptance by NMPA of

SHANGHAI, China, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company...

Related Keywords

Guangzhou ,Guangdong ,China ,Beijing ,Maryland ,United States ,Shanghai ,Suzhou ,Jiangsu ,San Francisco ,California ,Chinese ,Junshi Biosciences ,Eli Lilly ,Institute Of Microbiology Chinese Academy Science ,Ir Team ,Journal Of Arthritis Research Treatment ,National Medical Products Administration ,Systemic Lupus Erythematosus ,Arthritis Research ,Microbiology Chinese Academy ,Emergency Use Authorization ,Hong Kong Stock Exchange 1877 Hk ,